Detalles de la búsqueda
1.
Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis.
Int J Mol Sci
; 25(3)2024 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38338977
2.
New insights into pathogenesis point to HIV-1 Tat as a key vaccine target.
Arch Virol
; 166(11): 2955-2974, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34390393
3.
HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication.
Int J Mol Sci
; 22(1)2020 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33396807
4.
The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.
Int J Mol Sci
; 19(5)2018 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29747434
5.
HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
Retrovirology
; 13(1): 34, 2016 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27277839
6.
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial.
Retrovirology
; 12: 33, 2015 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25924841
7.
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study.
Retrovirology
; 11: 49, 2014 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-24961156
8.
Follow-up study of patients with cervical intraepithelial neoplasia grade 1 overexpressing p16Ink4a.
Int J Gynecol Cancer
; 23(9): 1663-9, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24172101
9.
Antitumour effects of antiretroviral therapy.
Nat Rev Cancer
; 4(11): 861-75, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15516959
10.
Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome-independent block of angiogenesis and matrix metalloproteinases.
Int J Cancer
; 128(1): 82-93, 2011 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20617515
11.
Impact of viral dose and major histocompatibility complex class IB haplotype on viral outcome in mauritian cynomolgus monkeys vaccinated with Tat upon challenge with simian/human immunodeficiency virus SHIV89.6P.
J Virol
; 84(17): 8953-8, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20554774
12.
HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection.
J Immunol
; 182(5): 2888-97, 2009 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19234184
13.
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
Nat Med
; 8(3): 225-32, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11875492
14.
Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART.
EBioMedicine
; 66: 103306, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33839064
15.
Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking.
Mol Cell Biochem
; 345(1-2): 105-18, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20721684
16.
HIV therapeutic vaccines aimed at intensifying combination antiretroviral therapy.
Expert Rev Vaccines
; 19(1): 71-84, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31957513
17.
HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction.
Mol Cancer Ther
; 19(12): 2476-2489, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33082275
18.
Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease.
Vaccines (Basel)
; 7(3)2019 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31454973
19.
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.
Front Immunol
; 10: 233, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30815001
20.
"cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies".
Expert Rev Vaccines
; 17(2): 115-126, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29243498